198 related articles for article (PubMed ID: 16978460)
1. Influence of equinus treatments on the vertical displacement of the body's centre of mass in children with cerebral palsy.
Massaad F; van den Hecke A; Renders A; Detrembleur C
Dev Med Child Neurol; 2006 Oct; 48(10):813-8. PubMed ID: 16978460
[TBL] [Abstract][Full Text] [Related]
2. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
Mousny M; Allington N
Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
[TBL] [Abstract][Full Text] [Related]
3. Determinants of responsiveness to botulinum toxin, casting, and bracing in the treatment of spastic equinus in children with cerebral palsy.
Yap R; Majnemer A; Benaroch T; Cantin MA
Dev Med Child Neurol; 2010 Feb; 52(2):186-93. PubMed ID: 20412253
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy.
Cardoso ES; Rodrigues BM; Barroso M; Menezes CJ; Lucena RS; Nora DB; Melo A
Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial.
Corry IS; Cosgrove AP; Duffy CM; McNeill S; Taylor TC; Graham HK
J Pediatr Orthop; 1998; 18(3):304-11. PubMed ID: 9600553
[TBL] [Abstract][Full Text] [Related]
6. Short-term effects of "botulinum toxin a" as treatment for children with cerebral palsy: kinematic and kinetic aspects at the ankle joint.
Galli M; Crivellini M; Santambrogio GC; Fazzi E; Motta F
Funct Neurol; 2001; 16(4):317-23. PubMed ID: 11853322
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group.
Koman LA; Mooney JF; Smith BP; Walker F; Leon JM
J Pediatr Orthop; 2000; 20(1):108-15. PubMed ID: 10641699
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A and dynamic equinus in children with cerebral palsy: new indication. Better than repeat casts.
Prescrire Int; 2001 Feb; 10(51):12-4. PubMed ID: 11503850
[TBL] [Abstract][Full Text] [Related]
9. Kinematic and kinetic evaluation of the ankle after intramuscular injection of botulinum toxin A in children with cerebral palsy.
Zürcher AW; Molenaers G; Desloovere K; Fabry G
Acta Orthop Belg; 2001 Dec; 67(5):475-80. PubMed ID: 11822078
[TBL] [Abstract][Full Text] [Related]
10. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients.
Papadonikolakis AS; Vekris MD; Korompilias AV; Kostas JP; Ristanis SE; Soucacos PN
Acta Orthop Scand; 2003 Dec; 74(6):749-55. PubMed ID: 14763710
[TBL] [Abstract][Full Text] [Related]
11. Use of a dynamic foot pressure index to monitor the effects of treatment for equinus gait in children with cerebral palsy.
Bennett D; Walsh M; O'Sullivan R; Gallagher J; O'Brien T; Newman CJ
J Pediatr Orthop; 2007; 27(3):288-94. PubMed ID: 17414011
[TBL] [Abstract][Full Text] [Related]
12. The effect of injections of botulinum toxin type A combined with casting on the equinus gait of children with cerebral palsy.
Hayek S; Gershon A; Wientroub S; Yizhar Z
J Bone Joint Surg Br; 2010 Aug; 92(8):1152-9. PubMed ID: 20675764
[TBL] [Abstract][Full Text] [Related]
13. Influence of gait pattern on the body's centre of mass displacement in children with cerebral palsy.
Massaad F; Dierick F; van den Hecke A; Detrembleur C
Dev Med Child Neurol; 2004 Oct; 46(10):674-80. PubMed ID: 15473171
[TBL] [Abstract][Full Text] [Related]
14. Neuronox versus BOTOX for spastic equinus gait in children with cerebral palsy: a randomized, double-blinded, controlled multicentre clinical trial.
Kim K; Shin HI; Kwon BS; Kim SJ; Jung IY; Bang MS
Dev Med Child Neurol; 2011 Mar; 53(3):239-44. PubMed ID: 21087238
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of delayed versus immediate serial casting after botulinum toxin injection for partially reducible spastic equinus.
Newman CJ; Kennedy A; Walsh M; O'Brien T; Lynch B; Hensey O
J Pediatr Orthop; 2007 Dec; 27(8):882-5. PubMed ID: 18209608
[TBL] [Abstract][Full Text] [Related]
16. Long-term use of botulinum toxin type A in children with cerebral palsy: treatment consistency.
Molenaers G; Schörkhuber V; Fagard K; Van Campenhout A; De Cat J; Pauwels P; Ortibus E; De Cock P; Desloovere K
Eur J Paediatr Neurol; 2009 Sep; 13(5):421-9. PubMed ID: 18977158
[TBL] [Abstract][Full Text] [Related]
17. Conservative management of dynamic equinus in diplegic children treated by gait improvement surgery.
Saraph V; Zwick EB; Steinwender C; Steinwender G; Linhart W
J Pediatr Orthop B; 2001 Oct; 10(4):287-92. PubMed ID: 11727370
[TBL] [Abstract][Full Text] [Related]
18. Spread of botulinum neurotoxin type a at standard doses is inherent to the successful treatment of spastic equinus foot in cerebral palsy: short-term neurophysiological and clinical study.
Frasson E; Dall'ora E; Bordignon M; Brigo F; Tocco P; Primon D; Didonè G; Vicentini S; Fiaschi A; Bertolasi L
J Child Neurol; 2012 May; 27(5):587-93. PubMed ID: 22114218
[TBL] [Abstract][Full Text] [Related]
19. The association of equinus and primary genu recurvatum gait in cerebral palsy.
Klotz MC; Wolf SI; Heitzmann D; Maier MW; Braatz F; Dreher T
Res Dev Disabil; 2014 Jun; 35(6):1357-63. PubMed ID: 24705489
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
Dai AI; Wasay M; Awan S
J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
